Dividend Buzzer: Dec 7, 2016 will mean $0.36 dividends for Nu Skin Enterprises, Inc. (NYSE:NUS) shareholders.

Dividend Buzzer: Dec 7, 2016 will mean $0.36 dividends for Nu Skin Enterprises, Inc. (NYSE:NUS) shareholders.

Nu Skin Enterprises, Inc. (NYSE:NUS) is expected to pay $0.36 on Dec 7, 2016. The indicated annual dividend is $1.42. Shareholders owning the stock before Nov 16, 2016 will be eligible to receive the payout. Based on Nu Skin Enterprises, Inc.’s current price of $52.56, the dividend is 0.68%. This dividend’s record date is Nov 18, 2016 and the announcement date is Nov 4, 2016. The stock decreased 0.08% or $0.04 during the last trading session, hitting $52.56. Nu Skin Enterprises, Inc. (NYSE:NUS) has risen 34.05% since April 13, 2016 and is uptrending. It has outperformed by 30.12% the S&P500.

Nu Skin Enterprises, Inc. is a direct selling firm that develops and distributes personal care products and nutritional supplements, and a range of other services and products. The company has a market cap of $2.87 billion. The Firm offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. It has a 21.38 P/E ratio. The Nu Skin brand offers a range of products, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care system and ageLOC Tru Face Essence Ultra anti-aging skin care serum.

Insitutional Activity: The institutional sentiment increased to 1.07 in 2016 Q2. Its up 0.03, from 1.04 in 2016Q1. The ratio is positive, as 30 funds sold all Nu Skin Enterprises, Inc. shares owned while 60 reduced positions. 36 funds bought stakes while 60 increased positions. They now own 40.71 million shares or 5.55% less from 43.10 million shares in 2016Q1.
Nuveen Asset Management Llc, a Illinois-based fund reported 223,129 shares. Lpl Ltd Liability last reported 0% of its portfolio in the stock. Aristotle Capital Boston Limited Liability Co holds 66,839 shares or 0.69% of its portfolio. Loudon Investment Mgmt Ltd owns 14,100 shares or 0.52% of their US portfolio. The Illinois-based Citadel Advsr Limited Liability has invested 0% in Nu Skin Enterprises, Inc. (NYSE:NUS). Vulcan Value Prtn Ltd Liability Corp has invested 0.4% of its portfolio in Nu Skin Enterprises, Inc. (NYSE:NUS). Qs Investors Lc owns 33,768 shares or 0.01% of their US portfolio. Gradient Invests Limited Liability accumulated 0% or 406 shares. Fmr Limited Liability Corporation has invested 0.03% of its portfolio in Nu Skin Enterprises, Inc. (NYSE:NUS). Cibc World accumulated 0% or 4,571 shares. New York State Common Retirement Fund last reported 231,397 shares in the company. The Georgia-based Signaturefd Limited Com has invested 0% in Nu Skin Enterprises, Inc. (NYSE:NUS). Susquehanna Grp Incorporated Llp has invested 0% of its portfolio in Nu Skin Enterprises, Inc. (NYSE:NUS). State Of Alaska Department Of Revenue has 4,480 shares for 0.02% of their US portfolio. Paradigm Cap Incorporated Ny accumulated 0.03% or 5,000 shares.

Insider Transactions: Since September 22, 2016, the stock had 0 insider purchases, and 2 sales for $5.68 million net activity. LUND STEVEN sold $3.75 million worth of Nu Skin Enterprises, Inc. (NYSE:NUS) on Wednesday, October 26. Shares for $1.92M were sold by LIPMAN ANDREW D on Thursday, September 22.

Nu Skin Enterprises, Inc. (NYSE:NUS) Ratings Coverage

Out of 9 analysts covering Nu Skin (NYSE:NUS), 3 rate it a “Buy”, 1 “Sell”, while 5 “Hold”. This means 33% are positive. Nu Skin has been the topic of 24 analyst reports since July 21, 2015 according to StockzIntelligence Inc. Citigroup maintained it with “Buy” rating and $45 target price in Tuesday, April 19 report. The company was maintained on Friday, April 29 by Pivotal Research. As per Thursday, July 30, the company rating was maintained by Canaccord Genuity. The firm earned “Hold” rating on Friday, June 3 by Jefferies. The stock of Nu Skin Enterprises, Inc. (NYSE:NUS) earned “Neutral” rating by Sidoti on Friday, February 12. The company was maintained on Friday, August 5 by Stifel Nicolaus. The company was maintained on Wednesday, October 7 by Canaccord Genuity. As per Friday, August 5, the company rating was maintained by Deutsche Bank. As per Thursday, September 22, the company rating was maintained by Jefferies. The firm has “Neutral” rating given on Tuesday, July 21 by Sterne Agee CRT.

More notable recent Nu Skin Enterprises, Inc. (NYSE:NUS) news were published by: Forbes.com which released: “Ex-Dividend Reminder: Deutsche Bank Contingent, Honeywell International and NU …” on November 14, 2016, also Prnewswire.com with their article: “Nu Skin Enterprises Announces Quarterly Dividend” published on November 03, 2016, Fool.com published: “Why Nu Skin Enterprises Inc. Stock Jumped 17% in June” on July 07, 2016. More interesting news about Nu Skin Enterprises, Inc. (NYSE:NUS) were released by: Fool.com and their article: “Why Nu Skin Enterprises Inc. Plunged Friday” published on February 12, 2016 as well as Prnewswire.com‘s news article titled: “Nu Skin Enterprises Announces Strategic Investment” with publication date: June 15, 2016.

NUS Company Profile

Nu Skin Enterprises, Inc., incorporated on September 4, 1996, is a global direct selling firm that develops and distributes personal care products and nutritional supplements, and a range of other services and products. The Firm offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Firm has activities in various geographic regions, including Greater China, North Asia, Americas, South Asia/Pacific, and Europe, the Middle East and Africa (EMEA). The Firm operates in the direct selling channel, primarily utilizing person-to-person marketing to promote and sell its products. The Firm offers Pharmanex nutritional supplements and Nu Skin personal care products under its ageLOC anti-aging brand. It also offers a limited number of other services and products, including household products and technology services.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment